Acute recurrent polyhydramnios: A combination of amniocenteses and NSAID may be curative rather than palliative

Fetal Diagnosis and Therapy

Volumn 22, Issue 3, 2007, Pages 186-189

  Rode, Line ^a   Bundgaard, Anne ^a   Skibsted, Lillian ^b   Ødum, Lars ^b   Jørgensen, Connie ^a   Langhoff Roos, Jens ^a  

^a Mental Health Services CPH   (Denmark)

^b ROSKILDE HOSPITAL   (Denmark)

Author keywords

Amniotic prolactin; Non steroidal anti inflammatory drugs and pregnancy; Recurrent polyhydramnios; Therapeutic amniocentesis

Indexed keywords

DICLOFENAC; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROLACTIN;

ADULT; AMNIOCENTESIS; AMNION FLUID; ARTICLE; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; HYDRAMNIOS; PREGNANCY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RECURRENT DISEASE; VAGINAL DELIVERY;

ACUTE DISEASE; ADULT; AMNIOCENTESIS; AMNIOTIC FLUID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFANT, NEWBORN; MALE; POLYHYDRAMNIOS; PREGNANCY; PROLACTIN; RECEPTORS, PROLACTIN; RECURRENCE;

EID: 34247160760     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098714     Document Type: Article

References (19)

1. Beischer N, Desmedt E, Ratten G, Sheedy M: The significance of recurrent polyhydramnios. Aust N Z J Obstet Gynecol 1993;33:25-30
2. Pitkin RM: Acute polyhydramnios recurrent in successive pregnancies. Obstet Gynecol 1976;48:42S-43S.
3. Shimizu T, Ihara Y, Kawaguchi K, Fujiwara T, Ando N: Human leukocyte antigen compatibility in a couple with recurrent hydramnios. Am J Obstet Gynecol 1988;159:463-464.
4. Weissmann A, Zimmer EZ: Acute polyhydramnios recurrent in four pregnancies. J Reprod Med 1987;32:65-66.
5. Sieck UV, Ohlsson A: Fetal polyuria and hydramnios associated with Bartter's syndrome. Obstet Gynecol 1984;63:22s-24s.
6. De Santis M, Cavaliere AF, Noia G; Masini L, Menini E, Caruso A: Acute recurrent polyhydramnios and amniotic prolactin. Prenat Diagn 2000;20:347-348.
7. Mamopoulos M, Assimakopoulos E, Reece EA, Andreou A, Zheng XZ, Mantalenakis S: Maternal Indomethacin therapy in the treatment of polyhydramnios. Am J Obstet Gynecol 1990;162:1225-1229.
8. Zamah NM, Gillieson MS, Walters JH, Hall PF: Sonographic detection of polyhydramnios: a five-year experience. Am J Obstet Gynecol 1982;143:523-525.
9. Hill LM, Lazebnik N, Many A, Martin JG: Resolving polyhydramnios: clinical significance and subsequent neonatal outcome. Ultrasound Obstet Gynecol 1995;6:421-424.
10. Souter D, Harding J, McCowan L, O'Donnell C, McLean E, Baxendale H: Antenatal Indomethacin: adverse fetal effects confirmed. Aust N Z J Obstet Gynaecol 1998;38:11-16.
11. Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI: Neonatal complications after the administration of Indomethacin in human pregnancy. N Engl J Med 1993;329:1602-1607.
12. Loe SM, Sanchez-Ramos L, Kaunitz AM: Assessing the neonatal safety of Indomethacin tocolysis: a systematic review with metaanalysis. Obstet Gynecol 2005;106:173-179.
13. Gordon MC, Narula K, O'Shaughnessy R, Barth WH: Complications of third-trimester amniocentesis using continuous ultrasound guidance. Obstet Gynecol 2002;99:255-259.
14. Nakanishi T, Suzomori N, Mizuno H, Suzuki K, Sato T, Tanemura M, Suzuki Y, Suzumori K: Elevated aldosterone in amniotic fluid and maternal blood has diagnostic potential in pregnancies complicated with a fetus of Bartter syndrome. Fetal Diagn Ther 2005;20:481-484.
15. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA: Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998;19:225-268.
16. Luciano AA, Varner MW: Decidual, amniotic fluid, maternal and fetal prolactin in normal and abnormal pregnancies. Obstet Gynecol 1984;63:384-388.
17. Tyson JE, Hwang P, Guyda H, Friesen HG: Studies of prolactin secretion in human pregnancy. Am J Obstet Gynecol 1972;113:14-20.
18. Kletzky OA, Rossman F, Bertolli SI, Platt LD, Mishell DR: Dynamics of human chorionic gonadotropin, prolactin, and growth hormone in serum and amniotic fluid throughout normal human pregnancy. Am J Obstet Gynecol 1985;151:878-884.
19. Mann SE, Nijland MJ, Ross MG: Mathematic modeling of human amniotic fluid dynamics. Am J Obstet Gynecol 1996;175:937-944.